Cargando…

P15-26. Leveraging motivators to participation in HIV vaccine research in the age of Obama

Detalles Bibliográficos
Autores principales:	Alexander, SB, Im, S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767723/ http://dx.doi.org/10.1186/1742-4690-6-S3-P227

Ejemplares similares

Motivators to participation in HIV vaccine trials and cancer trials: the application of personal and social categorization
por: Dhalla, S, et al.
Publicado: (2012)

P15-28. Attitudes and awareness of HIV vaccine research in HIV uninfected MSM in four US cities: Rochester, Boston, San Francisco and Philadelphia
por: Alexander, SB, et al.
Publicado: (2009)

OBAMA: OBAMA for Bayesian amino-acid model averaging
por: Bouckaert, Remco R.
Publicado: (2020)

P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation
por: Sitar, S, et al.
Publicado: (2009)

Obama widens access to government funded research
por: Davies, Edward
Publicado: (2013)

Barack Obama : en sus propias palabras /
por: Obama, Barack
Publicado: (2012)

P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand
por: Hemachandra, A, et al.
Publicado: (2009)

P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations
por: Lau, C, et al.
Publicado: (2009)

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
por: Mark, D, et al.
Publicado: (2009)

Barack Obama vs the LHC
Publicado: (2009)

Obama chez moi! The invasion of metropolitan France by the land planarian Obama nungara (Platyhelminthes, Geoplanidae)
por: Justine, Jean-Lou, et al.
Publicado: (2020)

Obama : de la esclavitud a la presidencia de los Estados Unidos
por: Garza Rivera, Antonio
Publicado: (2011)

Obama, Inc. : el éxito de una campaña de marketing /
por: Libert, Barry
Publicado: (2009)

Musings on genome medicine: the Obama effect
por: Nathan, David G, et al.
Publicado: (2009)

New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
por: Penezina, O, et al.
Publicado: (2012)

P15-07. Knowledge, attitudes, practices and willingness to participate in HIV vaccine trials among urban residents of Bamako, Mali, in West Africa, 2005–2009
por: Tounkara, K, et al.
Publicado: (2009)

Drinking motives and alcohol intervention for patients with HIV
por: Elliott, Jennifer C, et al.
Publicado: (2015)

P15-23. Community engagement strategies in the Canadian HIV vaccine initiative
por: Milsom, P, et al.
Publicado: (2009)

P15-27. Community involvement and ethics in HIV vaccine trial in Nigeria
por: Adeyemi, AO, et al.
Publicado: (2009)

P17-26. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: advances in vaccine design based on current preclinical success
por: De Groot, AS, et al.
Publicado: (2009)

Musings on genome medicine: the Obama effect redux
por: Nathan, David G, et al.
Publicado: (2009)

Dealing with research participants’ complaints in HIV/AIDS prevention studies: experiences from Zimbabwe
por: Gunda, R, et al.
Publicado: (2012)

P15-03. HIV vaccine funding trends entering a global recession: research and development (R&D) from 2000 – 2008
por: Fisher, K, et al.
Publicado: (2009)

Willingness to participate in HIV vaccine efficacy trials in a population of fishing communities, Uganda
por: Nanvubya, A, et al.
Publicado: (2012)

Barriers to participation in HIV vaccine trials and cancer trials: a cost-gain analysis
por: Dhalla, S, et al.
Publicado: (2012)

President Obama’s Humble Face: An Authentic or a Socially Desirable Posturing? A Study on Reactions to Obama’s Autobiographical Self-Disclosures
por: Mastropietro, Alessia, et al.
Publicado: (2022)

Embryonic Stem Cell Research: A Decade of Debate from Bush to Obama
por: Murugan, Varnee
Publicado: (2009)

P02.39. Leveraging grant awards to enhance the research infrastructure at a CAM institution
por: Pohlman, K, et al.
Publicado: (2012)

DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
por: Morgan, C, et al.
Publicado: (2012)

P15-11. Preventive HIV vaccine acceptability: a systematic review and meta-analysis
por: Newman, PA, et al.
Publicado: (2009)

P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative
por: Sarazin, V, et al.
Publicado: (2009)

P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis
por: Sarazin, V, et al.
Publicado: (2009)

P15-02. Participation in immune-based therapy trial excludes participation in future trials: solving this problem
por: Routy, J, et al.
Publicado: (2009)

Safety of percutaneous tracheostomy in trauma patients
por: Maldonado, IM, et al.
Publicado: (2010)

P14-11. Educating community medical providers about HIV vaccine induced seropositivity
por: Mark, KE, et al.
Publicado: (2009)

Julio Ramirez Honored for Outstanding Mentorship by President Obama
por: Dunbar, Gary L.
Publicado: (2011)

Epistemic Consultants and the Regulation of Policy Knowledge in the Obama Administration
por: Wright, Jack, et al.
Publicado: (2020)

Obama, Trump and Indian foreign policy under Modi
por: Ganguly, Šumit
Publicado: (2021)

Motivating men who have sex with men to get tested for HIV
por: Blas, Magaly M, et al.
Publicado: (2012)

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine
por: Martinon, F, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_o9i0acsjm24lpqvb6jtlnka45o